Loading...
Please wait, while we are loading the content...
The consequences of 'Brexit' for drug discovery and development, and the regulatory implications
| Content Provider | Scilit |
|---|---|
| Author | Golding, Bernard T. Waring, Michael J. |
| Copyright Year | 2018 |
| Related Links | https://www.tandfonline.com/doi/pdf/10.1080/17460441.2018.1463215?needAccess=true |
| Ending Page | 585 |
| Page Count | 3 |
| Starting Page | 583 |
| ISSN | 17460441 |
| e-ISSN | 1746045X |
| DOI | 10.1080/17460441.2018.1463215 |
| Journal | Expert Opinion on Drug Discovery |
| Issue Number | 7 |
| Volume Number | 13 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2018-04-15 |
| Access Restriction | Open |
| Subject Keyword | Journal: Expert Opinion On Drug Discovery Applied Mathematics Brexit European Medicines Agency Ema Food & Drug Administration Fda Drug Discovery Drug Development Drug Regulation |
| Content Type | Text |
| Subject | Drug Discovery |